Abstract

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is one of the key redox-sensitive proteins whose activity is largely affected by oxidative modifications at its highly reactive cysteine residue in the enzyme’s active site (Cys149). Prolonged exposure to oxidative stress may cause, inter alia, the formation of intermolecular disulfide bonds leading to accumulation of GAPDH aggregates and ultimately to cell death. Recently these anomalies have been linked with the pathogenesis of Alzheimer’s disease. Novel evidences indicate that low molecular compounds may be effective inhibitors potentially preventing the GAPDH translocation to the nucleus, and inhibiting or slowing down its aggregation and oligomerization. Therefore, we decided to establish the ability of naturally occurring compound, piceatannol, to interact with GAPDH and to reveal its effect on functional properties and selected parameters of the dehydrogenase structure. The obtained data revealed that piceatannol binds to GAPDH. The ITC analysis indicated that one molecule of the tetrameric enzyme may bind up to 8 molecules of polyphenol (7.3 ± 0.9). Potential binding sites of piceatannol to the GAPDH molecule were analyzed using the Ligand Fit algorithm. Conducted analysis detected 11 ligand binding positions. We indicated that piceatannol decreases GAPDH activity. Detailed analysis allowed us to presume that this effect is due to piceatannol ability to assemble a covalent binding with nucleophilic cysteine residue (Cys149) which is directly involved in the catalytic reaction. Consequently, our studies strongly indicate that piceatannol would be an exceptional inhibitor thanks to its ability to break the aforementioned pathologic disulfide linkage, and therefore to inhibit GAPDH aggregation. We demonstrated that by binding with GAPDH piceatannol blocks cysteine residue and counteracts its oxidative modifications, that induce oligomerization and GAPDH aggregation.

Highlights

  • Many different hypotheses attempting to explain the formation of changes leading to the development of Alzheimer’s Disease (AD) have appeared in recent years

  • It has been shown that glyceraldehyde-3-phosphate dehydrogenase (GAPDH) plays a substantial role in this processes

  • It is well established that besides the traditional role in a glucose metabolism, Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is implicated in the regulation of cell proliferation, DNA repair, tRNA export, membrane fusion and transport, cytoskeletal dynamics, cell death and many other cellular processes [5]

Read more

Summary

Introduction

Many different hypotheses attempting to explain the formation of changes leading to the development of Alzheimer’s Disease (AD) have appeared in recent years. Takeuchi’s team [11,12,13,14] indicated that GAPDH in aggregated form exhibits significant functional similarity to aggregates formed by the amyloid beta peptide. Both in vitro and in vivo studies have demonstrated that GAPDH aggregates accelerate Aβ amyloidogenesis and contribute to neuronal cell death [13]. The presented data confirm the significant contribution of oxidative-modified GAPDH in the pathogenesis of Alzheimer’s disease [11,12,13,14]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call